APA (7th ed.) Citation

Madar-Balakirski, N., Rosner, A., Melamed, S., Politi, B., Steiner, M., Tamir, H., . . . Nyska, A. (2022). Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs. Archives of Toxicology, 96(3), 859. https://doi.org/10.1007/s00204-021-03214-w

Chicago Style (17th ed.) Citation

Madar-Balakirski, Noa, et al. "Preliminary Nonclinical Safety and Immunogenicity of an RVSV-ΔG-SARS-CoV-2-S Vaccine in Mice, Hamsters, Rabbits and Pigs." Archives of Toxicology 96, no. 3 (2022): 859. https://doi.org/10.1007/s00204-021-03214-w.

MLA (9th ed.) Citation

Madar-Balakirski, Noa, et al. "Preliminary Nonclinical Safety and Immunogenicity of an RVSV-ΔG-SARS-CoV-2-S Vaccine in Mice, Hamsters, Rabbits and Pigs." Archives of Toxicology, vol. 96, no. 3, 2022, p. 859, https://doi.org/10.1007/s00204-021-03214-w.